4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Hua Medicine (Shanghai) Ltd. (2552) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Shanghai, China with about 328 employees. Its market capitalization is roughly CNY 3 billion. In the fiscal year ended 2025-12-31, 2552 reported CNY 493M in revenue and CNY 1.1B in net income.
Hua Medicine (Shanghai) Ltd. engages in the development and commercialization of drugs for the treatment of diabetes in China.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CNY 493M | CNY 256M | CNY 77M | CNY 18M | — |
| Gross Profit | CNY 280M | CNY 125M | CNY 37M | CNY 8M | — |
| Operating Income (EBIT) | (CNY 136M) | (CNY 353M) | (CNY 289M) | (CNY 241M) | — |
| Net Income | CNY 1.1B | (CNY 250M) | (CNY 211M) | (CNY 204M) | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | CNY 1.5B | CNY 1.5B | CNY 1.7B | CNY 1.1B |
| Total Liabilities | CNY 463M | CNY 1.7B | CNY 1.6B | CNY 842M |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2552 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms